Fulcrum Therapeutics Inc. (FULC) Tops Q3 EPS by 8c; Cash and Cash Equivalents of $240.3M

Go back to Fulcrum Therapeutics Inc. (FULC) Tops Q3 EPS by 8c; Cash and Cash Equivalents of $240.3M

Fulcrum Therapeutics Inc. (FULC) Files $150M Mixed Shelf

November 4, 2021 7:48 AM EDT

Fulcrum Therapeutics Inc. (NASDAQ: FULC) files $150,000,000 mixed shelf of:

Debt Securities

Common Stock

Preferred Stock

Depositary Shares

Units

Warrants

... More